Olaparib

CAS 763113-22-0

Overview

Olaparib, sold under the brand name Lynparza, is a medication for the maintenance treatment of BRCA-mutated advanced ovarian cancer in adults

Anant Labs manufacture and furnish high quality Olaparib impurities for global markets. Our Olaparib EP Impurities are used by API manufacturers and fully integrated pharmaceutical companies worldwide.

In Stock

Olaparib

Cat. No. ANT-OPB-00CAS 763113-22-0In Stock

Technical Data

Cat. No.ANT-OPB-00

CAS763113-22-0

Mol. FormulaC₂₄H₂₃FN₄O₃

Mol. Weight434.47 g/mol

IUPAC4-[[3-[4-(cyclopropanecarbonyl)piperazine-1-carbonyl]-4-fluorophenyl]methyl]-2H-phthalazin-1-one

SMILESC1CC1C(=O)N2CCN(CC2)C(=O)C3=C(C=CC(=C3)CC4=NNC(=O)C5=CC=CC=C54)F

InChIInChI=1S/C24H23FN4O3/c25-20-8-5-15(14-21-17-3-1-2-4-18(17)22(30)27-26-21)13-19(20)24(32)29-11-9-28(10-12-29)23(31)16-6-7-16/h1-5,8,13,16H,6-7,9-12,14H2,(H,27,30)

InChI KeyFDLYAMZZIXQODN-UHFFFAOYSA-N

Note: We are upgrading our system, Cat No will change.

Synonyms

4-[[3-[[4-(Cyclopropylcarbonyl)-1-piperazinyl]carbonyl]-4-fluorophenyl]methyl]-1(2H)-phthalazinoneOlaparib763113-22-0AZD2281LynparzaAZD-2281KU-0059436AZD 2281KU-59436WOH1JD9AR8